Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy

PERCEPÇÃO DOS HEMATOLOGISTAS BRASILEIROS SOBRE O LINFOMA DO MANTO: FATORES PROGNÓSTICOS, TRATAMENTO E IMPACTO DA PANDEMIA DE COVID-19

L.G. Figorelle, F.D.R.P. Oliveira, R. Schaffel, V.V. Santos

10.1016/j.htct.2020.10.398

Hematol Transfus Cell Ther. 2020;42 Supl 2:237-8

Open access

Twitter

Facebook

ADENOCARCINOMA DE JUNÇÃO ESOFAGOGÁSTRICA COM SUPEREXPRESSÃO DO HER 2 EM PACIENTE COM MIELOMA MÚLTIPLO: RELATO DE UMA RARA ASSOCIAÇÃO

F.M. Carlotto, J. Pastorello, D.R. Almeida

10.1016/j.htct.2020.10.414

Hematol Transfus Cell Ther. 2020;42 Supl 2:247

Open access

Twitter

Facebook

Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study

E. Terpos, A. Symeonidis, S. Delimpasi, E. Zamagni, E. Katodritou, E. Rivolti, M. Kyrtsonis, D. Fotiou, N. Kanellias, M. Migkou, M. Roussou, M. Gavriatopoulou, E. Hatjiharissi, M. Cavo, M. Dimopoulos

10.1016/j.htct.2020.09.043

Hematol Transfus Cell Ther. 2020;42 Supl 1:22-3

Open access

Twitter

Facebook

COVID-19 infection in cancer patients: a systematic review and meta-analysis with emphasizing the risk and prognosis stratification

G. Elgohary

10.1016/j.htct.2020.09.046

Hematol Transfus Cell Ther. 2020;42 Supl 1:24-5

Open access

Twitter

Facebook

Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19

N. Yarali, Y. Akcabelen, Y. Unal, A. Ozkaya-Parlakay

10.1016/j.htct.2020.09.051

Hematol Transfus Cell Ther. 2020;42 Supl 1:27

Open access

Twitter

Facebook

Acute ischemic stroke presentation of otherwise asymptomatic covid-19 patient

E. Aksoy, Y. Tor, S. Kalayoglu Besisik, A. Alibeyoglu, M. Kose, N. Senkal, A. Cagatay, M. Erelel, T. Tukek

10.1016/j.htct.2020.09.082

Hematol Transfus Cell Ther. 2020;42 Supl 1:46

Open access

Twitter

Facebook

Hepcidin level changes in type 2 diabetes

A. Gawaly, F. Atyia

10.1016/j.htct.2020.09.102

Hematol Transfus Cell Ther. 2020;42 Supl 1:57

Open access

Twitter

Facebook

Reactive lymphocytes in blood film of a covid-19 iraqi patient: a case report

A. Al-Ani

10.1016/j.htct.2020.09.104

Hematol Transfus Cell Ther. 2020;42 Supl 1:57-8

Open access

Twitter

Facebook

A study of hematological disease prevalence in covid-19 pandemic: a single center experience

V. Gursoy

10.1016/j.htct.2020.09.105

Hematol Transfus Cell Ther. 2020;42 Supl 1:58

Open access

Twitter

Facebook

Hematologic manifestations associated with deficiency of adenosine deaminase 2 and a novel ada2 variant

E. Hanafy, M. Al Twaijri, N. Al Bolowi

10.1016/j.htct.2020.09.135

Hematol Transfus Cell Ther. 2020;42 Supl 1:75

Open access

Twitter

Facebook

Previous 57 58 59 Page 60 61 62 Next

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Indexed in:

Follow us:

Special content about coronavirus SARS-CoV-2 (COVID-19) in Hematology, Transfusion and Cell Therapy

Subscribe to our newsletter